168 related articles for article (PubMed ID: 26653111)
1. Insulin Sensitivity and β-Cell Function in SGA Children Treated With GH and GnRHa: Results of a Long-Term Trial.
van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2016 Feb; 101(2):705-13. PubMed ID: 26653111
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
van der Steen M; Lem AJ; van der Kaay DC; Bakker-van Waarde WM; van der Hulst FJ; Neijens FS; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
[TBL] [Abstract][Full Text] [Related]
3. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
4. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
6. Randomized GH trial with two different dosages in combination with a GnRH analogue in short small for gestational age children: effects on metabolic profile and serum GH, IGF1, and IGFBP3 levels.
van der Kaay D; Bakker B; van der Hulst F; Mul D; Mulder J; Schroor E; van Elswijk D; Rowaan I; Willeboer M; de Ridder M; Hokken-Koelega A
Eur J Endocrinol; 2010 May; 162(5):887-95. PubMed ID: 20176737
[TBL] [Abstract][Full Text] [Related]
7. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment.
Goedegebuure WJ; van der Steen M; Kerkhof GF; Hokken-Koelega ACS
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436961
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
[TBL] [Abstract][Full Text] [Related]
10. Cognition, Health-Related Quality of Life, and Psychosocial Functioning After GH/GnRHa Treatment in Young Adults Born SGA.
Goedegebuure WJ; van der Steen M; de With JL; Hokken-Koelega A
J Clin Endocrinol Metab; 2018 Nov; 103(11):3931-3938. PubMed ID: 30137415
[TBL] [Abstract][Full Text] [Related]
11. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment.
Willemsen RH; Willemsen SP; Hokken-Koelega AC
J Clin Endocrinol Metab; 2008 Sep; 93(9):3449-54. PubMed ID: 18559910
[TBL] [Abstract][Full Text] [Related]
13. Puberty in growth hormone-treated children born small for gestational age (SGA).
Boonstra V; van Pareren Y; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Dec; 88(12):5753-8. PubMed ID: 14671164
[TBL] [Abstract][Full Text] [Related]
14. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
15. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
17. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
de Zegher F; Ong K; van Helvoirt M; Mohn A; Woods K; Dunger D
J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in short children born small for gestational age: effects of growth hormone treatment and postponement of puberty.
Lem AJ; Jobse I; van der Kaay DC; de Ridder MA; Raat H; Hokken-Koelega AC
Horm Res Paediatr; 2012; 77(3):170-9. PubMed ID: 22441140
[TBL] [Abstract][Full Text] [Related]
20. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
Audí L; Carrascosa A; Esteban C; Fernández-Cancio M; Andaluz P; Yeste D; Espadero R; Granada ML; Wollmann H; Fryklund L;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2709-15. PubMed ID: 18445665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
